Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


Kraig Biocraft Laboratories, Inc. (KBLB.OB) Continues To Grow Its Intellectual Property Portfolio

Source: http://Blog.QualityStocks.net/?p=17373
Posted on Monday, August 24th, 2009 | In Market Commentary, Small & Micro Cap
Contributed by: QualityStocks (http://QualityStocks.net) -

Kraig Biocraft Laboratories, Inc., the Michigan-based company using genetic engineering to allow silkworms to produce spider silk, is making use of some of the most advanced insect-related genetic engineering techniques known. Scientists have already produced the first transgenic silkworms, and other scientists have discovered the sequence of genes used by spiders to produce silk. The brilliance of Kraig’s approach is the bringing together of researchers from both of these fields in a collaborative effort to produce commercially viable quantities of spider silk.

Kraig Biocraft has acquired the exclusive rights in this field to the genetic sequences patented by the University of Wyoming, and the genetic engineering technology developed by the University of Notre Dame. The company is now working in conjunction with the leading genetic scientists at these universities to produce a transgenic variety of silkworm capable of producing the elusive spider silk.

The process is tedious and exacting, but the goal could be worth tens of billions of dollars. Spider silk exceeds all known fibers in its ability to absorb energy without breaking. This makes it a potential super fiber for a host of ballistic resistant, medical, industrial, and even fashion related applications. Discovering a way to make such silk commercially viable would be a major scientific achievement, of exceeding value to companies like DuPont that currently dominate the technical textiles market.

As part of the company’s intellectual property portfolio, Kraig Biocraft has the exclusive rights to use the patented spider silk gene sequences in silkworms within the United States. The company’s intellectual property portfolio also includes a separate U.S. provisional patent application for certain methodologies, genetic sequences, organic polymers, and composites of fibers.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Last 5 posts by QualityStocks





About QualityStocks (http://QualityStocks.net)

Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis.

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.